Form 4: Aspen Aerogels Executive Virginia Johnson Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Virginia Johnson, CLO, GC, Secretary & CCO of Aspen Aerogels, reports acquisition and disposal of common stock and derivative securities.

Summary

  • On March 5, 2025, Virginia Johnson, CLO, GC, Secretary & CCO of Aspen Aerogels, reported transactions involving Aspen Aerogels Inc. [ASPN] common stock and derivative securities.
  • Johnson disposed of 936 shares of common stock at $7.84 per share to cover tax withholding requirements related to vesting Restricted Stock Units (RSUs).
  • Johnson acquired 26,307 shares of common stock through the vesting of RSUs.
  • Following these transactions, Johnson beneficially owns 26,196 shares of common stock directly and 52,503 shares including RSUs.
  • Johnson also acquired 37,804 stock options with an exercise price of $7.84, vesting in three equal installments on March 5, 2026, 2027, and 2028, and expiring on March 5, 2035.
  • Additionally, Johnson acquired 52,614 Performance Share Units (PSUs) that vest on March 5, 2028, based on the company's total shareholder return relative to the Russell 2000 Index components over a three-year performance period.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects standard compensation practices and insider transactions. There's no indication of unusual activity or cause for alarm, but also no explicit positive news.

Positives

  • The granting of RSUs, stock options, and PSUs to a key executive aligns their interests with those of the shareholders.
  • The vesting of RSUs indicates that previous performance milestones have been met.

Negatives

  • The disposal of shares to cover tax obligations, while standard, slightly reduces the executive's direct shareholding.

Risks

  • The vesting of PSUs is contingent on the company's performance relative to the Russell 2000 Index, introducing performance-based uncertainty.
  • Future stock transactions by the executive could impact the stock price.

Future Outlook

The vesting schedules for RSUs, stock options, and PSUs suggest a long-term commitment from the executive and alignment with the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

  • Stock option and RSU grants are common compensation practices in publicly traded companies, particularly in growth-oriented sectors like Aspen Aerogels' industry.
  • Vesting schedules of three years are typical for such grants, aligning executive incentives with long-term value creation.
  • Performance-based equity awards, like the PSUs tied to relative TSR, are increasingly used to incentivize outperformance compared to peers.

Stakeholder Impact

  • The transactions have a minor impact on shareholders, reflecting standard executive compensation practices.
  • Employees may view the equity grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/05/2025Date of stock transactions, including disposal of shares for tax withholding, acquisition of shares via RSU vesting, and grant of stock options and PSUs.
03/05/2026First vesting date for one-third of the granted stock options and RSUs.
03/05/2027Second vesting date for one-third of the granted stock options and RSUs.
12/31/2027End of the performance period for the Performance Share Units (PSUs).
03/05/2028Final vesting date for one-third of the granted stock options and RSUs, and the vesting date for the PSUs.
03/05/2035Expiration date of the granted stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.